-
Nature Cancer | AI Foundation Model for Non-Invasive Prostate Cancer Diagnosis and Grading
Research Background Prostate cancer is the second most common malignancy among men worldwide. In China, its incidence has been rising steadily due to an aging population and increasingly Westernized lifestyles,…
-
A New Chapter in Comprehensive Management of Renal Cell Carcinoma | Professors Youyan Guan and Xiongjun Ye Provide In-Depth Insights
On August 22–23, 2025, the 2025 Pujiang Uro-Oncology Conference was held in Shanghai, bringing together leading experts to discuss advances in urologic oncology. This article is based on the pre-conference session presented by Professor Youyan Guan (Cancer Hospital, Chinese Academy of Medical Sciences) and Professor Xiongjun Ye, titled “Comprehensive Management of Renal Cancer Patients.” Their…
-
Transformative Advances in mHSPC Treatment Strategies
Editor’s Note: On August 22–23, 2025, the highly anticipated 2025 Pujiang Uro-Oncology Conference was held in Shanghai, gathering leading experts in urologic oncology from across China and abroad. Among the key topics was the optimization of treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC). Professor Xinan Sheng from Peking University Cancer Hospital delivered an insightful…
-
Good News | Academician Xu Zhang Elected Chair of ARUS, Professor Gang Zhu Elected Secretary-General
Recently, the Asian Robotic Urology Section (ARUS), one of the subspecialty committees under the Urological Association of Asia (UAA), held its leadership election and a chair handover ceremony during the UAA Annual Meeting. China’s Academician Xu Zhang has been officially elected as Chair of ARUS, and Professor Gang Zhu has been appointed Secretary-General.
-
Latest International Advances in Modern Lymphoma Treatment: Professor Qi Shunan Interprets Highlights of the ILROG Annual Meeting
Oncology Frontier – Hematology Frontier：As one of the organizers of this conference, which is a grand event in the international lymphoma radiation oncology field, can you briefly introduce the main…
-
Professor Fang Liu: Unveiling the Application and Future Prospects of CAR-T Therapy in Acute Myeloid Leukemia丨13th Lu Daopei Hematology Conference
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease Foundation, and hosted by the Beijing Lu Daopei Hematology Institute. The conference gathered world-leading hematology experts and focused on hematopoietic stem cell transplantation, cellular therapy,…
-
Professor Jiong Hu: Clinical Management of Cytomegalovirus Infection After Transplantation and the Ruijin Protocol
I. Overview of Post-Transplant Viral Infections Viral infections are among the most common complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and remain a major cause of infection-related mortality. Frequently…
-
Professor Peihua Lu on CD7 CAR-T丨13th Lu Daopei Hematology Conference
________________________________________ PART 1 In clinical studies and practice, particularly those pioneered by the Lu Daopei team, what efficacy potential and limitations has CD7 CAR-T shown in relapsed/refractory (r/r) T-cell malignancies?…
Connecting Medical Expertise through Media